BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34010423)

  • 1. Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer.
    Kantor O; King TA; Shak S; Russell CA; Giuliano AE; Hortobagyi GN; Burstein HJ; Winer EP; Dey T; Sparano JA; Mittendorf EA
    J Natl Cancer Inst; 2021 Nov; 113(12):1744-1750. PubMed ID: 34010423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast Cancer.
    O'Cearbhaill R; Gannon JM; Prichard RS; Walshe JM; McDermott E; Quinn CM
    Pathobiology; 2019; 86(2-3):77-82. PubMed ID: 30347405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
    Kantor O; Burstein HJ; King TA; Shak S; Russell CA; Giuliano AE; Hortobagyi GN; Winer EP; Korde LA; Sparano JA; Mittendorf EA
    Ann Surg Oncol; 2022 Dec; 29(13):8016-8023. PubMed ID: 35900648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Significance of the Oncotype DX Recurrence Score in T
    Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
    Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
    Kim JY; Lim JE; Jung HH; Cho SY; Cho EY; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
    Breast Cancer Res Treat; 2018 Oct; 171(3):737-745. PubMed ID: 29931426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
    Breaux A; Turner B; Wu X; Rai SN; Riley EC; Mandadi M; Sanders MA
    Clin Breast Cancer; 2019 Feb; 19(1):e261-e269. PubMed ID: 30509870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer.
    Jang N; Choi JE; Kang SH; Bae YK
    Virchows Arch; 2019 Feb; 474(2):193-200. PubMed ID: 30474738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
    Ding S; Wu J; Lin C; Andriani L; Goh C; Chen W; Li Y; Shen K; Zhu L
    Oncologist; 2019 Nov; 24(11):e1014-e1023. PubMed ID: 31019021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomy.
    Wu SG; Wang J; Lian CL; Lei J; Hua L; Lin Q; Chen YX; He ZY
    Breast; 2020 Jun; 51():2-10. PubMed ID: 32172191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
    Lombardi A; Vitale V; Nigri G; Olivieri C; Mastrangeli MR; Bizzaglia E; Amanti C
    Breast J; 2020 Jul; 26(7):1265-1269. PubMed ID: 32180300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
    Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
    JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.
    Mittendorf EA; Ballman KV; McCall LM; Yi M; Sahin AA; Bedrosian I; Hansen N; Gabram S; Hurd T; Giuliano AE; Hunt KK
    J Clin Oncol; 2015 Apr; 33(10):1119-27. PubMed ID: 25488970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the AJCC Eighth-Edition Prognostic Staging System for Breast Cancer in a Latin American Cohort.
    Cervera-Bonilla S; Rodríguez-Ossa P; Vallejo-Ortega M; Osorio-Ruiz A; Mendoza-Diaz S; Orozco-Ospino M; Lehmann-Mosquera C; Duarte-Torres C; Ángel-Aristizábal J; Guzmán-Abisaab L; Garcia-Mora M; Diaz-Casas S
    Ann Surg Oncol; 2021 Oct; 28(11):6014-6021. PubMed ID: 33830356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].
    Sun GY; Wang SL; Tang Y; Yang Y; Fang H; Wang JY; Jing H; Zhang JH; Jin J; Song YW; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Wang WH; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):615-623. PubMed ID: 31434454
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
    Lee SB; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Son BH; Ahn SH
    Breast Cancer Res Treat; 2018 Jun; 169(2):257-266. PubMed ID: 29388016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.